Mind Medicine (MindMed) (NASDAQ:MNMD) Research Coverage Started at Robert W. Baird

Robert W. Baird initiated coverage on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a research report released on Tuesday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $27.00 target price on the stock. MNMD has been the topic of a number of other reports. Royal Bank of Canada […]

Leave a Reply

Your email address will not be published.

Previous post Insider Selling: The TJX Companies, Inc. (NYSE:TJX) EVP Sells $2,033,200.00 in Stock
Next post Merus (NASDAQ:MRUS) Price Target Increased to $93.00 by Analysts at Guggenheim